Abstract
ABSTRACT Pharmaceutical companies influence whether we perceive conditions as relevant to the medical sector and in need of pharmaceutical intervention (pharmaceuticalization). Recently, through coordinated media and professional campaigns, pharmaceutical companies are coming to influence our understanding of bodily size. Beyond merely affecting conversations about how weight should be understood and engaged with in healthcare, however, pharmaceutical companies are swaying how society approaches weight stigma. By elevating certain voices, those of organizations and clinicians with whom they partner, and not others, including fat acceptance activists, pharmaceutical companies are having a regressive impact on body acceptance veiled as “obesity” stigma advocacy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
